incretin comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tirzepatide 是一种由 39 个氨基酸组成的合成肽，分子结构上以 GIP 序列为骨架并引入脂肪酸侧链修饰，使其能够同时与葡萄糖依赖性促胰岛素多肽（GIP）受体和胰高血糖素样肽-1（GLP-1）受体结合。这种双重激动特性使它在同类肽类药物中区别于选择性 GLP-1 受体激动剂。该分子最早由一家制药公司在 2010 年代报道，随后进入糖尿病与体重管理领域的临床研究。
在生理层面，GIP 与 GLP-1 均为肠道内分泌细胞分泌的肠促胰素，进食后参与胰岛素分泌调节与胃排空抑制。Tirzepatide 通过同时激活这两条信号通路，使胰岛素分泌的葡萄糖依赖性增强，并延缓冲胃排空、降低食欲信号。与单一 GLP-1 激动相比，双靶点作用在血糖控制和体重变化上的效应幅度更大，但具体贡献比例仍在研究之中。
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
| Property | Value | Notes |
|---|---|---|
| 分子类型 | 合成修饰肽 | 39 个氨基酸，含脂肪酸侧链 |
| 受体靶点 | GIP 与 GLP-1 受体 | 双重激动剂 |
| 分子量 | 约 4.8 kDa | 以游离肽计 |
| 外观 | 白色至类白色粉末 | 冻干形态常见 |
| 溶解性 | 可溶于水及水性缓冲液 | 溶解后宜低温保存 |
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
These drugs act as antagonists or inverse agonists of the 5-HT2A, α1-adrenergic, and H1 receptors, as partial agonists of the 5-HT1A receptor, and as inhibitors of the transporters. mCPP is an antagonist of the 5-HT2B receptor, an agonist of the 5-HT1A, 5-HT2C, and 5-HT3 receptors, and acts as a partial agonist of the human 5-HT2A and 5-HT2C receptors.
Keeping the temperatures sufficiently low is accomplished with specially designed containers and dry ice, but dry ice is only allowed in limited quantities on airplanes as the gases released via sublimation may be toxic. In the United States, the Federal Aviation Administration (FAA) limits the amount of dry ice on a Boeing 777-224 to 3,000 lb (1,400 kg), but it temporarily allowed United Airlines to transport up to 15,000 lb (6,800 kg)—nearly 1 million doses—between Brussels and Chicago. The Centers for Disease Control and Prevention (CDC) tasked McKesson Corporation with vaccine distribution in the U.S.; the company handled all major vaccines except Pfizer's. American Airlines, Boeing, and Delta Air Lines are also working to increase dry ice transportation capacity, and American, Delta, and United each operate their own cold storage networks in the US. FedEx and UPS have installed ultra-cold freezers at air cargo hubs in Europe and North America, and UPS can manufacture 1,200 lb (540 kg) of dry ice per hour.
== Bibliography == “Inka Hydraulic Engineering”, University of Colorado at Denver. 19 September 2006. Brown, Jeff L. “Water Supply and Drainage Systems at Machu Picchu” 19 September 2006 Wright, Kenneth R. “Machu Picchu: Prehistoric Public Works.” American Public Works Association APWA Reporter, 17 November 2003 [1] Archived 2009-08-31 at the Wayback Machine D’Altroy, Terence N. and Christine A. Hastorf. Empire and Domestic Economy. New York: Kluwer Academic/Plenum Publishers, 2001. Wright, Kenneth, Jonathan M. Kelly, Alfredo Valencia Zegarra. “Machu Pichu: Ancient Hydraulic Engineering”. Journal of Hydraulic Engineering, October 1997. Bauer, Brian. The Development of the Inca State. University of Texas Press, Austin, 1992. Hyslop, John. Inka Settlement Planning. University of Texas Press, Austin, 1990.
== Contraindications == Thiopental should be used with caution in cases of liver disease, Addison's disease, myxedema, severe heart disease, severe hypotension, a severe breathing disorder, or a family history of porphyria. Co-administration of pentoxifylline and thiopental causes death by acute pulmonary edema in rats. This pulmonary edema was not mediated by cardiac failure or by pulmonary hypertension but was due to increased pulmonary vascular permeability.
Sources: en.wikipedia.org
The period during which a trial is attempting to identify and enroll participants. Recruitment activities can include advertising and other ways of soliciting interest from possible participants (NLM) Recruitment status
All spermatophytes, except for the family of grasses and cereals (Poaceae), contain 7S (vicilin) and 11S (legumin) soy protein-like globulin storage proteins; or only one of these globulin proteins. S denotes Svedberg, sedimentation coefficients. Oats and rice are anomalous in that they also contain a majority of soybean-like protein. Cocoa, for example, contains the 7S globulin, which contributes to cocoa/chocolate taste and aroma, whereas coffee beans (coffee grounds) contain the 11S globulin responsible for coffee's aroma and flavor. Vicilin and legumin proteins belong to the cupin superfamily, a large family of functionally diverse proteins that have a common origin and whose evolution can be followed from bacteria to eukaryotes including animals and higher plants. 2S albumins form a major group of homologous storage proteins in many dicot species and in some monocots but not in grasses (cereals). Soybeans contain a small but significant 2S storage protein. 2S albumin are grouped in the prolamin superfamily. Other allergenic proteins included in this 'superfamily' are the non-specific plant lipid transfer proteins, alpha amylase inhibitor, trypsin inhibitors, and prolamin storage proteins of cereals and grasses. Peanuts, for instance, contain 20% 2S albumin but only 6% 7S globulin and 74% 11S. It is the high 2S albumin and low 7S globulin that is responsible for the relatively low lysine content of peanut protein compared to soy protein.
carbonization 1. The conversion of organic compounds, such as those found in biological organisms, into other forms of carbon or carbonic residues by heating or burning, or during fossilization. 2. The process of coating a substance with carbon residues such as charcoal, or of causing a substance to become scorched, blackened, or charred.
Navy Warrant Officer Class 1 D Lennon Chief Petty Officer M Rodway Army Warrant Officer Class 1 Matthew James Anderson, Royal Corps of Signals Warrant Officer Class 1 Rupert St John Hardington Banfield, , Army Air Corps Warrant Officer Class 1 Peter Bernthal, Corps of Royal Electrical and Mechanical Engineers Staff Sergeant Troy David Binding Corps of Royal Electrical and Mechanical Engineers Warrant Officer Class 2 Aarron David Butterworth, Corps of Royal Engineers Warrant Officer Class 1 (now Captain) Adam Daniel Cooksey, Royal Regiment of Artillery Warrant Officer Class 1 (now Captain) Leslie Trevor Dinsmore, Corps of Royal Electrical and Mechanical Engineers Warrant Officer Class 2 Darren Lee Duckitt, The Royal Yorkshire Regiment Warrant Officer Class 2 Kulbahadur Ghale, The Royal Gurkha Rifles Warrant Officer Class 1 (now Captain) Marc Kevin Giles, , The Mercian Regiment Warrant Officer Class 1 Philip John Greenway, Royal Regiment of Artillery Warrant Officer Class 1 Adam Charles Ireland, The Parachute Regiment Warrant Officer Class 1 Manojkumar Jugjali, The Royal Gurkha Rifles Warrant Officer Class 1 Carley Lorraine Lambert, Royal Regiment of Artillery Warrant Officer Class 1 James Lee Lightfoot, Royal Regiment of Artillery Warrant Officer Class 1 (now Captain) Daniel Andrew Long, The Rifles Warrant Officer Class 1 James Derek Mayoh, Royal Regiment of Artillery Warrant Officer Class 1 (now Captain) Stuart Russell McCreadie, Royal Corps of Signals Warrant Officer Class 1 Peter Steven Meager, Corps of Royal Electrical and Mechanical Engineers Warrant Officer Class 1 (now Captain) Ryan Daniel O'Neill, The Royal Regiment of Scotland Warrant Officer Class 1 James Edward Phillips, Corps of Royal Electrical and Mechanical Engineers Warrant Officer Class 2 Michael John Potts, Royal Army Medical Corps Warrant Officer Class 2 Prakash Rai, Royal Army Medical Corps Warrant Officer Class 2 Kyle Reains, Irish Guards Warrant Officer Class 1 James Wright Reid, Corps of Royal Electrical and Mechanical Engineers Warrant Officer Class 1 James Oliver Richardson, Royal Regiment of Artillery Warrant Officer Class 1 Aran Christopher Rushe, Royal Army Medical Corps Warrant Officer Class 1 Grant Spencer Sewell-Jones, Royal Corps of Army Music Warrant Officer Class 1 Paul Sheenan, Corps of Royal Electrical and Mechanical Engineers Warrant Officer Class 1 Melanie Louise Silvester, Adjutant General's Corps (Staff and Personnel Support Branch) Warrant Officer Class 1 (now Captain) Garry Andrew Smurthwaite, The Parachute Regiment Warrant Officer Class 2 David Robert John Steel, The Royal Scots Dragoon Guards Warrant Officer Class 1 John Ian Sweeney, Army Air Corps Warrant Officer Class 2 (now Captain) Trevor Albert Tuhey, Royal Army Physical Training Corps Warrant Officer Class 1 Russell James Underwood, Corps of Royal Electrical and Mechanical Engineers Warrant Officer Class 2 George Ferguson Francis Wong Vesi, Adjutant General's Corps (Staff and Personnel Support Branch) Warrant Officer Class 1 (now Captain) Jonathan George Werrett, The Mercian Regiment Warrant Officer Class 1 Joseph Thomas Williams, Corps of Royal Electrical and Mechanical Engineers Warrant Officer Class 1 Michael James Williams, Royal Corps of Signals Warrant Officer Class 1 David Wood, Corps of Royal Electrical and Mechanical Engineers Warrant Officer Class 1 Craig Michael Woodall, Royal Army Veterinary Corps Warrant Officer Class 2 Robert Steven Young, Welsh Guards Air Force Warrant Officer (now Flight Lieutenant) J. Blinkhorn Warrant Officer (now Flight Lieutenant) H. Dimeck Warrant Officer (now Flight Lieutenant) F.E. Hunt Warrant Officer D.P. Burke Warrant Officer W.O.R Clements Warrant Officer N.W. Cook Master Aircrew A.R. Davey, Warrant Officer J.C. Foxall Warrant Officer D.G. Jackson Warrant Officer K.E. Jones Warrant Officer E.L. Kerslake Warrant Officer M.E. Larkin Warrant Officer D.A. Lawrence Warrant Officer R. Laycock Warrant Officer B. Moore Warrant Officer C.L.S Old Master Aircrew S.R. Parsons Warrant Officer K.N. Phillips Warrant Officer S.G. Rowbotham Warrant Officer A. Wilson Warrant Officer P.B. Wilson, Warrant Officer S.M. Wooles Acting Warrant Officer K.S. Edwards Acting Warrant Officer A.S. MacDonald Flight Sergeant M.J. Moore Flight Sergeant J.C. O'Grady Flight Sergeant J.A. Simpkins Flight Sergeant C.A. Smith Flight Sergeant P.S. Ware Flight Sergeant L.A. Williams Chief Technician D.G. Bristow Sergeant E.P. Jones
== Initiatives == In 2022 ASCP received a multi-year grant over $1M to promote the CDC OneLab initiative, a network of laboratory professionals and testers to support rapid, large-scale responses to public health emergencies.
Sources: en.wikipedia.org
=== Elongation stages === Loading: Analogous to the starting stage, each module loads its specific amino acid onto its PCP-domain. Condensation: The C-domain catalyzes the amide bond formation between the thioester group of the growing peptide chain from the previous module with the amino group of the current module. The extended peptide is now attached to the current PCP-domain. Condensation-Cyclization: Sometimes the C-domain is replaced by a Cy-domain, which, in addition to the amide bond formation, catalyzes the reaction of the serine, threonine, or cysteine sidechain with the amide-N, thereby forming oxazolidines and thiazolidine, respectively. Epimerization: Sometimes an E-domain epimerizes the innermost amino acid of the peptide chain into the D-configuration. This cycle is repeated for each elongation module.
In addition to their actions as reuptake inhibitors of serotonin, some SSRIs are also, coincidentally, ligands of the sigma receptors. Fluvoxamine is an agonist of the σ1 receptor, while sertraline is an antagonist of the σ1 receptor, and paroxetine does not significantly interact with the σ1 receptor. None of the SSRIs have significant affinity for the σ2 receptor. Fluvoxamine has by far the strongest activity of the SSRIs at the σ1 receptor. High occupancy of the σ1 receptor by clinical dosages of fluvoxamine has been observed in the human brain in positron emission tomography (PET) research. Agonism of the σ1 receptor by fluvoxamine may have beneficial effects on cognition. In contrast to fluvoxamine, the relevance of the σ1 receptor in the actions of the other SSRIs is uncertain and questionable due to their low affinity for the receptor relative to the SERT.
The original liquid formulation without EDTA was returned to the market in the US in May 2008. In 2009, Genzyme acquired the rights to Leukine from Bayer, including the manufacturing facility in the Seattle area. In March 2018 the label was extended to use as a countermeasure for acute radiation syndrome. In February 2018, Partner Therapeutics, Inc. acquired the global rights to develop, manufacture, and commercialize Leukine (sargramostim) from Sanofi.
The glycerol released by lipase action is phosphorylated by glycerol kinase in the liver (the only tissue in which this reaction can occur), and the resulting glycerol 3-phosphate is oxidized to dihydroxyacetone phosphate. The glycolytic enzyme triose phosphate isomerase converts this compound to glyceraldehyde 3-phosphate, which is oxidized via glycolysis, or converted to glucose via gluconeogenesis.
=== Others, associated with the city === Rex Cherryman (1896–1928), American actor, died here Jean-Paul Sartre (1905–1980), philosopher, taught at the Lycée François-Ier Patrick Demarchelier (1943–2022), fashion photographer, spent his childhood in Le Havre Christine Lagarde (born 1956), IMF managing director, grew up in Le Havre René Viénet (born 1944), sinologist Suzzane Fontaine (1894-1979), paternal grandmother of Pope Leo XIV
Sources: en.wikipedia.org
它属于合成修饰肽，同时激动 GIP 与 GLP-1 两种肠促胰素受体。这类分子通常被称为双重肠促胰素受体激动剂，与选择性 GLP-1 激动剂在靶点范围上不同。
分子上的脂肪酸侧链使其与血浆白蛋白结合增强，显著延长循环半衰期。半衰期延长后，稳定血药浓度可在较长的给药间隔内维持，因此常见用法为每周一次。
同时激活两条肠促胰素通路可能在胰岛素分泌、胃排空和食欲调节上产生叠加效应。与单靶点相比，临床研究中观察到的血糖与体重变化幅度通常更明显，但各通路的具体贡献比例尚无定论。
It activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. This dual activity separates it from agents that act on only one of the two receptors. The relative contribution of each receptor to clinical effects remains an open area of study.